![Tom Strange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Strange
Privat kapitalinvesterare på
iCON Infrastructure LLP
Profil
Tom Shaw Le Strange is currently a Director at iCON Infrastructure LLP.
Previously, he was a Director at MiroBio Ltd. in 2022.
He graduated from the University of Cambridge in 2012 and completed his undergraduate degree at The University of Nottingham in 2008.
Aktiva positioner av Tom Strange
| Företag | Position | Start |
|---|---|---|
iCON Infrastructure LLP
 iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Privat kapitalinvesterare | 2023-06-01 |
Tidigare kända positioner av Tom Strange
| Företag | Position | Slut |
|---|---|---|
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Privat kapitalinvesterare | 2022-11-01 |
Tom Stranges utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
98
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Finance |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Health Technology |
